apaflurane has been researched along with fluticasone in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.33) | 18.2507 |
2000's | 36 (83.72) | 29.6817 |
2010's | 6 (13.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lipworth, BJ; Orr, LC; Sims, EJ; Wilson, AM | 1 |
Braunstein, G; Sharma, R | 1 |
Cripps, A; Riebe, M; Schulze, M; Woodhouse, R | 1 |
Andrews, S; Callejas, S; Daley-Yates, PT; Kunka, R; Pimazzoni, M; Squassante, L; Ziviani, L | 1 |
Bons, J; Bugnas, B; Evano-Celli, I; Legendre, M; Prud'Homme, A; Stuart, AM; Tonnel, AB | 1 |
Lundback, B; Perruchoud, AP; Sykes, AP; Yigla, M | 1 |
Ayres, JG; Millar, AB; Sykes, AP | 1 |
Fairfax, AJ | 1 |
Bye, A; Daley-Yates, PT; Falcoz, C; Mackie, AE; McDowall, JE; Ventresca, P | 1 |
Lipworth, BJ | 1 |
Aubier, M; Gans, SJ; Wettenger, R | 1 |
Ashurst, IC; Chowdhry, BZ; Davies-Cutting, CJ; Michael, Y; Riley, T; Snowden, MJ | 1 |
Hajiro, T; Ishihara, K | 1 |
Currie, GP; Fowler, SJ; Lipworth, BJ | 1 |
Boudreau, RJ; Davidson, PJ; Hasselquist, BE; Leach, CL | 1 |
Currie, GP; Fowler, SJ; Lipworth, BJ; McFarlane, L; Orr, LC; Sims, EJ; Wilson, AM | 1 |
Derham, A; Hedgeland, P; Holden, J; Langley, SJ; Sharma, RK; Woodcock, A | 1 |
Currie, GP; Fowler, SJ; Lipworth, BJ; Orr, LC; Sims, EJ; Wilson, AM | 1 |
Addlestone, R; Anderson, PB; Cantini, L; Jones, J; Langley, SJ; Mooney, P; Rossetti, A | 1 |
Emeryk, A; Gilles, J; Lyttle, B; Panov, M; Wixon, C | 1 |
Baitinger, L; Dorinsky, P; Greos, LS; Gross, G; Nelson, HS; Scott, C; Wolfe, JD | 1 |
Donnell, D; Van Schayck, CP | 1 |
Kossack, WS; Nelson, HS; Silkoff, PE; Thongngarm, T | 1 |
Chervinsky, P; Crim, C; Herje, NE; Noonan, MJ; Pinnas, JL; Scott, CA; Weinstein, SF; Wu, W | 1 |
Conway, MM; Crim, C; Herje, NE; LaForce, CF; Lumry, WR; Pearlman, DS; Scott, CA; Wu, WW | 1 |
Dorinsky, P; Ellsworth, A; House, K; Nathan, RA; Rooklin, A; Schoaf, L; Scott, C | 1 |
Hayashi, N; Hirose, M; Horiguchi, T; Ito, T; Kondo, R; Miyazaki, J; Ohira, D; Sasaki, Y; Shiga, M; Tachikawa, S; Torigoe, H | 1 |
Carranza-Rosenzweig, J; Crim, C; Lincourt, WR; Locantore, NW; Sheth, K; Wasserman, RL | 1 |
Ceruti, E; Crim, C; Kleha, JF; Maspero, JF; Mehta, R; Qaqundah, PY; Scott, CA; Sugerman, RW; Wu, W | 1 |
Chesrown, S; Hendeles, L; Hochhaus, G; Khan, Y; Shuster, JJ; Spencer, T; Tang, Y | 1 |
Adachi, M; Hirata, K; Ichinose, M; Kokubu, F; Ohbayashi, H; Ohta, K; Sano, Y; Tamura, G; Tohda, Y; Yasuba, H | 1 |
Cahn, A; Collins, DA; Kathman, S; Kim, KT; Kunka, RL; Levy, AL; Matz, P; Mehta, R; Milgrom, H; Su, SF; Welch, MJ; Yoon, YK | 1 |
Marriott, C; Martin, GP; Murnane, D | 1 |
Damoiseaux, JG; Dompeling, E; Hendriks, HJ; Jöbsis, Q; Kester, AD; Rijkers, GT; Robroeks, CM; van de Kant, KD; van Vliet, D; Wodzig, WK | 1 |
Andersen, LB; Edin, HM; Ho, SY; Ortega, HG; Schoaf, L; Scott-Wilson, CA | 1 |
Banno, M; Ibata, H; Matsushita, R; Niimi, T; Sato, S | 1 |
Akazawa, K; Arakawa, M; Gejyo, F; Hasegawa, T; Koya, T; Ota, K; Sakagami, T; Sekikawa, T; Suzuki, E; Toyabe, S | 1 |
Adachi, M; Ohbayashi, H | 1 |
Church, T; Finlay, WH; Hoe, S; Lewis, D; Shemirani, FM; Vehring, R | 1 |
Barion, F; Barnes, N; Burden, A; Chisholm, A; Colice, G; Dorinsky, P; Hillyer, EV; Israel, E; Lee, AJ; Martin, RJ; Polos, P; Price, D; Roche, N; von Ziegenweidt, J | 1 |
Chand, R; Kuehl, PJ; Leach, CL; McDonald, JD | 1 |
Barletta, B; Blake, DR; Cooper, DM; Leu, SY; Meinardi, S; Nussbaum, E; Radom-Aizik, S; Randhawa, I; Shin, HW; Yoonessi, L | 1 |
Berlinski, A; Hatley, RH; Pritchard, JN; von Hollen, D | 1 |
3 review(s) available for apaflurane and fluticasone
Article | Year |
---|---|
The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma.
Topics: Administration, Topical; Aerosol Propellants; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Chemistry, Pharmaceutical; Fluticasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated | 2000 |
[Inhaled corticosteroids: first-line therapy in asthma].
Topics: Administration, Inhalation; Administration, Topical; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Budesonide; Clinical Trials as Topic; Fluticasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Patient Education as Topic; Pregnenediones | 2001 |
The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults.
Topics: Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Double-Blind Method; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Multicenter Studies as Topic; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Treatment Outcome; Vital Capacity | 2004 |
30 trial(s) available for apaflurane and fluticasone
Article | Year |
---|---|
Differences in lung bioavailability between different propellants for fluticasone propionate.
Topics: Adult; Aerosol Propellants; Androstadienes; Anti-Asthmatic Agents; Biological Availability; Chlorofluorocarbons; Dose-Response Relationship, Drug; Fluticasone; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Lung; Single-Blind Method | 1999 |
From hydrofluoroalkane pressurized metered dose inhalers (pMDIs) and comparability with chlorofluorocarbon pMDIs.
Topics: Adult; Aerosol Propellants; Androstadienes; Anti-Asthmatic Agents; Chlorofluorocarbons; Cross-Over Studies; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male | 2000 |
Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Androstadienes; Anti-Asthmatic Agents; Asthma; Chlorofluorocarbons; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Middle Aged; Peak Expiratory Flow Rate; Therapeutic Equivalency; Treatment Outcome | 2000 |
Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Chlorofluorocarbons; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Middle Aged; Peak Expiratory Flow Rate; Therapeutic Equivalency; Treatment Outcome | 2000 |
Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Chlorofluorocarbons; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Middle Aged; Peak Expiratory Flow Rate; Therapeutic Equivalency; Treatment Outcome | 2000 |
Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
Topics: Administration, Inhalation; Adult; Aerosol Propellants; Androstadienes; Anti-Asthmatic Agents; Chlorofluorocarbons; Cross-Over Studies; Double-Blind Method; Fluticasone; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Infusions, Intravenous; Male; Nebulizers and Vaporizers | 2000 |
Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Eosinophils; Equipment Design; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Leukocyte Count; Male; Middle Aged; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Treatment Outcome | 2001 |
Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchial Provocation Tests; Bronchodilator Agents; Drug Administration Schedule; Drug Therapy, Combination; Fluticasone; Humans; Hydrocarbons, Fluorinated; Middle Aged; Outcome Assessment, Health Care; Quality of Life; Respiratory Function Tests; Salmeterol Xinafoate | 2002 |
Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers.
Topics: Administration, Inhalation; Administration, Topical; Adult; Aerosol Propellants; Aerosols; Androstadienes; Anti-Inflammatory Agents; Beclomethasone; Chlorofluorocarbons; Cross-Over Studies; Female; Fluticasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Lung; Male; Middle Aged; Particle Size; Radionuclide Imaging; Radiopharmaceuticals; Technetium | 2002 |
Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate.
Topics: Administration, Inhalation; Administration, Topical; Adult; Aerosol Propellants; Androstadienes; Anti-Inflammatory Agents; Asthma; Chlorofluorocarbons; Cross-Over Studies; Female; Fluticasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Male; Single-Blind Method | 2002 |
Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness.
Topics: Adult; Aerosol Propellants; Airway Resistance; Androstadienes; Bronchial Hyperreactivity; Bronchial Provocation Tests; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Methacholine Chloride; Middle Aged; Nebulizers and Vaporizers; Treatment Outcome | 2002 |
Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma.
Topics: Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchoconstrictor Agents; Bronchodilator Agents; Creatinine; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Fluticasone; Forced Expiratory Flow Rates; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Methacholine Chloride | 2002 |
Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Topics: Adult; Aged; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Budesonide; Chemistry, Pharmaceutical; Chlorofluorocarbons; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Least-Squares Analysis; Male; Middle Aged; Patient Compliance; Peak Expiratory Flow Rate; Severity of Illness Index; Treatment Outcome; United Kingdom; Vital Capacity | 2002 |
Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children.
Topics: Administration, Inhalation; Adolescent; Androstadienes; Asthma; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Nebulizers and Vaporizers; Probability; Respiratory Function Tests; Severity of Illness Index; Treatment Outcome | 2003 |
Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Drug Therapy, Combination; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Time Factors; Treatment Outcome | 2003 |
Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Topics: Administration, Inhalation; Adult; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchodilator Agents; Chlorofluorocarbons; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Pharmaceutical Solutions; Pulmonary Ventilation; Single-Blind Method; Suspensions | 2005 |
Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Androstadienes; Asthma; Bronchodilator Agents; Child; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Metered Dose Inhalers; Middle Aged; Treatment Outcome | 2005 |
Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroids.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Androstadienes; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Metered Dose Inhalers; Middle Aged; Peak Expiratory Flow Rate | 2006 |
Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Topics: Adolescent; Adult; Aerosol Propellants; Aged; Aged, 80 and over; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child; Double-Blind Method; Drug Administration Schedule; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Spirometry; Time Factors; Treatment Outcome | 2006 |
Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
Topics: Adrenergic beta-Agonists; Adult; Aerosol Propellants; Androstadienes; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Cross-Over Studies; Drug Combinations; Drug Therapy, Combination; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Medical Records; Metered Dose Inhalers; Middle Aged; Particle Size; Peak Expiratory Flow Rate | 2006 |
Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Patient Satisfaction; Powders; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome | 2006 |
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Child, Preschool; Circadian Rhythm; Double-Blind Method; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Infant; Male; Metered Dose Inhalers; Treatment Outcome | 2006 |
Lung bioavailability of hydrofluoroalkane fluticasone in young children when delivered by an antistatic chamber/mask.
Topics: Administration, Inhalation; Androstadienes; Biological Availability; Child; Child, Preschool; Cross-Over Studies; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Infant; Lung; Male; Masks; Static Electricity | 2006 |
[A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Topics: Administration, Inhalation; Aerosol Propellants; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Fluticasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Middle Aged; Quality of Life | 2007 |
Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
Topics: Administration, Inhalation; Aerosol Propellants; Androstadienes; Anti-Asthmatic Agents; Area Under Curve; Asthma; Child; Child, Preschool; Chlorofluorocarbons; Cough; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Fluticasone; Half-Life; Headache; Humans; Hydrocarbons, Fluorinated; Hydrocortisone; Male; Metered Dose Inhalers; Nausea; Respiratory Tract Infections | 2008 |
Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma.
Topics: Administration, Inhalation; Androstadienes; Anti-Inflammatory Agents; Asthma; Beclomethasone; Biomarkers; Breath Tests; Child; Cross-Over Studies; Dinoprost; Female; Fluticasone; Forced Expiratory Volume; Humans; Hydrocarbons, Fluorinated; Hydrogen Peroxide; Inflammation; Interleukins; Male; Nitrates; Nitric Oxide; Nitrites; Prospective Studies; Treatment Outcome; Vital Capacity | 2008 |
Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life.
Topics: Administration, Inhalation; Adult; Aerosol Propellants; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Double-Blind Method; Drug Combinations; Female; Fluticasone; Fluticasone-Salmeterol Drug Combination; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Quality of Life; Salmeterol Xinafoate; Surveys and Questionnaires; Treatment Outcome; United States | 2009 |
The usefulness of inspiratory flow rate during inhalation corticosteroid therapy in asthma.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Androstadienes; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Female; Fluticasone; Glucocorticoids; Humans; Hydrocarbons, Fluorinated; Inhalation; Male; Middle Aged; Respiratory Function Tests | 2009 |
Nasal Deposition of HFA-Beclomethasone, Aqueous Fluticasone Propionate and Aqueous Mometasone Furoate in Allergic Rhinitis Patients.
Topics: Adult; Aerosol Propellants; Aerosols; Beclomethasone; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Cross-Over Studies; Fluticasone; Humans; Hydrocarbons, Fluorinated; Middle Aged; Mometasone Furoate; Nasal Mucosa; Rhinitis, Allergic; Tomography, Emission-Computed, Single-Photon | 2015 |
Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aerosol Propellants; Aerosols; Albuterol; Breath Tests; Bronchodilator Agents; California; Chemistry, Pharmaceutical; Drug Monitoring; Exhalation; Female; Fluticasone; Forced Expiratory Volume; Healthy Volunteers; Humans; Hydrocarbons, Fluorinated; Male; Maximal Midexpiratory Flow Rate; Medication Adherence; Middle Aged; Predictive Value of Tests; Vital Capacity | 2015 |
10 other study(ies) available for apaflurane and fluticasone
Article | Year |
---|---|
The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
Topics: Administration, Inhalation; Aerosol Propellants; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Chlorofluorocarbons; Fluticasone; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers | 2000 |
Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
Topics: Aerosol Propellants; Albuterol; Androstadienes; Anti-Asthmatic Agents; Bronchodilator Agents; Fluticasone; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Particle Size | 2000 |
Re: Dose proportionality of fluticosone proportionate hydrofluoroalkane pressurized metered dose inhalers (pMDIS) and comparability with chlorofluorocarbon pMDIS.
Topics: Aerosol Propellants; Androstadienes; Anti-Inflammatory Agents; Biological Availability; Chlorofluorocarbons; Drug Delivery Systems; Fluticasone; Humans; Hydrocarbons, Fluorinated; Lung; Therapeutic Equivalency | 2001 |
Characterisation of the aggregation behaviour in a salmeterol and fluticasone propionate inhalation aerosol system.
Topics: Administration, Inhalation; Aerosols; Albuterol; Androstadienes; Anti-Asthmatic Agents; Chemistry, Pharmaceutical; Chlorofluorocarbons, Ethane; Chlorofluorocarbons, Methane; Drug Interactions; Fluticasone; Hydrocarbons, Fluorinated; Salmeterol Xinafoate | 2001 |
Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals.
Topics: Administration, Inhalation; Aerosol Propellants; Aerosols; Albuterol; Androstadienes; Bronchodilator Agents; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Fluticasone; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Particle Size; Polyethylene Glycols; Pressure; Reproducibility of Results; Salmeterol Xinafoate; Technology, Pharmaceutical | 2008 |
Analysis of inhaled corticosteroid selection in patients with bronchial asthma using a questionnaire survey--effects of age, gender, and disease severity.
Topics: Administration, Inhalation; Age Factors; Androstadienes; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Drug Prescriptions; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Japan; Male; Middle Aged; Retrospective Studies; Sex Factors; Surveys and Questionnaires; Treatment Outcome | 2009 |
Influence of dentures on residual inhaled corticosteroids in the mouths of elderly asthma patients.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Androstadienes; Asthma; Beclomethasone; Bronchodilator Agents; Candidiasis, Oral; Dentures; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Mouth; Mouthwashes | 2012 |
In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Topics: Administration, Inhalation; Aerosol Propellants; Androstadienes; Beclomethasone; Bronchodilator Agents; Chemistry, Pharmaceutical; Drug Delivery Systems; Ethanol; Fluticasone; Glucocorticoids; Glycerol; Humans; Humidity; Hydrocarbons, Fluorinated; Metered Dose Inhalers; Models, Anatomic; Mouth; Pharynx; Rheology; Temperature | 2013 |
Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone.
Topics: Adult; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Cohort Studies; Female; Fluticasone; Health Care Costs; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Middle Aged; Retrospective Studies | 2013 |
Delay Between Shaking and Actuation of a Hydrofluoroalkane Fluticasone Pressurized Metered-Dose Inhaler.
Topics: Administration, Inhalation; Aerosols; Asthma; Bronchodilator Agents; Child; Child, Preschool; Female; Fluticasone; Humans; Hydrocarbons, Fluorinated; Male; Metered Dose Inhalers; Pressure; Random Allocation; Time Factors | 2018 |